China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2026)

China SXT Pharmaceuticals has reported Inventory for 9 years, with the latest figure at $777059.0 in Q1 2026.

• On a quarterly basis, Inventory fell 6.16% year-over-year to $777059.0 in Q1 2026; TTM through Mar 2026 was $777059.0, a 6.16% decrease from a year earlier, with the FY2026 full-year figure at $777059.0, down 6.16% from the prior year.
• Inventory was $777059.0 for Q1 2026 at China SXT Pharmaceuticals, up from $751346.0 in the prior quarter.
• The five-year high for Inventory was $1.0 million in Q1 2022, with the low at $493214.0 in Q3 2023.
• Average Inventory over 5 years is $743191.9, with a median of $777059.0 recorded in 2026.
• The sharpest annual moves came in 2023 and 2024: Inventory sank 47.79% in 2023, then soared 75.83% in 2024.
• Over 5 years, Inventory stood at $628186.0 in 2022, then retreated by 21.49% to $493214.0 in 2023, then jumped by 75.83% to $867233.0 in 2024, then slipped by 13.36% to $751346.0 in 2025, then grew by 3.42% to $777059.0 in 2026.
• The last three Inventory figures came in at $777059.0 (Q1 2026), $751346.0 (Q3 2025), and $828053.0 (Q1 2025), per Business Quant data.